AVGO:NASDAQBroadcom Inc. Analysis
Data as of 2026-03-09 - not real-time
$330.45
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Broadcom (AVGO) is trading at $330.45, just above its 20‑day SMA of $329.60 but below the 50‑day SMA of $334.32, indicating a modest short‑term edge while the broader trend remains neutral (RSI 51, MACD histogram +0.52). Volume is increasing, and the MACD line has crossed above its signal, a bullish technical signal that aligns with the recent double‑beat earnings and the company’s bold AI chip sales forecast of $100B+ by 2027. Fundamentally, the stock carries a high trailing PE of 69.4x versus the semiconductor industry average of 36.2x, suggesting it is currently overvalued, yet a forward PE of 19.1x and a strong EPS outlook (forward EPS $17.31) point to significant growth potential. The balance sheet shows $11.1B cash offset by $40.5B debt, yielding a high debt‑to‑equity of 166%, but robust operating cash flow ($29.7B) and free cash flow ($25.4B) support dividend sustainability and future investment. Dividend yield sits at 0.79% with a payout ratio under 50%, which, combined with a solid ROE of 33%, suggests the dividend is defensible despite leverage. Analyst consensus is heavily bullish (strong‑buy, median target $475), implying a potential upside of roughly 40% from current levels, though the DCF fair value of $141 highlights a stark valuation gap.
Overall, the stock presents a compelling growth story anchored by AI and infrastructure software tailwinds, but investors must weigh the high valuation, elevated beta (≈1.7), and debt load against the strong cash generation and market positioning. The near‑term price action may test the $307 support and $352 resistance zones, while the medium‑to‑long‑term narrative remains anchored in expanding AI‑driven demand and disciplined capital returns.
Overall, the stock presents a compelling growth story anchored by AI and infrastructure software tailwinds, but investors must weigh the high valuation, elevated beta (≈1.7), and debt load against the strong cash generation and market positioning. The near‑term price action may test the $307 support and $352 resistance zones, while the medium‑to‑long‑term narrative remains anchored in expanding AI‑driven demand and disciplined capital returns.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- Bullish MACD crossover with rising volume
- Price testing near $307 support and $352 resistance
- Elevated valuation relative to peers
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong AI chip sales outlook and double‑beat earnings
- Forward PE of 19.1x indicating attractive growth pricing
- Analyst consensus strong‑buy with median target $475
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained cash flow supporting dividend and debt repayment
- Strategic positioning in data‑center and AI infrastructure
- Long‑term growth trajectory despite current overvaluation
Key Metrics & Analysis
Financial Health
Revenue Growth16.40%
Profit Margin36.57%
P/E Ratio69.4
ROE33.37%
ROA10.62%
Debt/Equity166.03
P/B Ratio5.6
Op. Cash Flow$29.7B
Free Cash Flow$25.4B
Industry P/E36.2
Technical Analysis
TrendNeutral
RSI51.0
Support$307.20
Resistance$352.34
MA 20$329.60
MA 50$334.32
MA 200$320.70
MACDBullish
VolumeIncreasing
Fear & Greed Index68.77
Valuation
Fair Value$141.01
Target Price$467.62
Upside/Downside41.51%
GradeOvervalued
TypeGrowth
Dividend Yield0.79%
Risk Assessment
Beta1.70
Volatility37.72%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.